聂军,于光烈,骆抗先,戴子森,严燕,王安位.国产血源性乙肝疫苗免疫原性、安全性和保护效果观察[J].Chinese journal of Epidemiology,1988,9(6):332-335 |
国产血源性乙肝疫苗免疫原性、安全性和保护效果观察 |
A Study on the Immunogenicity, Safety and Protective Efficacy of a Plasmaderived Hepatitis B Vaccine Made in China |
|
DOI: |
KeyWord: 乙型肝炎 血源性疫苗 免疫接种 |
English Key Word: Hepatitis B Plasma-derived vaccine Vaccination Intramuscular injection |
FundProject: |
|
Hits: 2040 |
Download times: 495 |
Abstract: |
本文对96名HBV血清标志均阴性的健康成年男性,用随机、双盲、对照实验,采用0、1、6方案,经肌肉和皮内两种途径接种乙肝疫苗并随访7个月,以观察国产血源性乙肝疫苗的免疫效果。首次接种后7个月,肌肉组和皮内组抗-HBs应答率分别为86.7%和76.2%,抗-HBs GMT分别为115和96mIU/ml。两者差别均不显著。疫苗组和对照组HBV感染率分别为2.0%和17.6%,保护率为88.6%。疫苗接种者无严重不良反应。表明国产血源性乙肝疫苗有较好的免疫原性;在观察期间内,两种途径免疫效果相似,且安全可靠。 |
English Abstract: |
Ninety and six adults who were confirmed to be negative for all HBV sero-markers were injected plasma-derived hepatitis B vaccine intramuscularly and intradermally respectively in a randomized, double blind, placebo-controlled trial. The Vaccine was injected at 0, 1,6 months and followed up for 7 months. At 7 months after the first injection, anti-HBs Sero-conversion rate in intramuscular injection group was 86.7% and intradermal grouo was 76.2%, and anti-HBs GMT were 115 and 96 mIU/ml, res-p ectively. ihere were no Significant differences either in anti-HBs seroconversion rate or anti-HBs GMT between the two groups. Infection rates of HBV in vaccineted and placebo-controlled group were 2.0 and 17.6% respectively. protective rate of vaccine was 88.6%. No serious side effects in vaccinated group were observed. |
View Fulltext
Html FullText
View/Add Comment Download reader |
Close |
|
|
|